Skip to main content

Lead the response

Through this Strategic Plan, Hepatitis Australia will strive to provide thought leadership that stimulates discussion and learning. Our organisation is resolved to achieve both ‘equity’ and ‘impact’. These reflect our determination to achieve elimination by focusing on the greatest gaps and highest-impact priorities. We will measure success by progress leaving no one behind: viral hepatitis will only be over when it is over for everyone.

To achieve elimination, we depend upon the excellence and efforts of community, research, clinical and government partners. In this plan, we highlight Hepatitis Australia’s contribution to partnerships and the convening role we will play bringing partners together to find solutions and build consensus.

Implementation plan

 

What we will achieve How we will achieve it
Less stigma and discrimination
  • Work with partners to assess emerging evidence and promote strategies to reduce the impacts of stigma and discrimination in the lives of people affected by hepatitis B and hepatitis C.

  • Build coalitions with others working to reduce stigma and discrimination related to hepatitis B and hepatitis C in healthcare and other settings.
A stronger workforce
  • Create opportunities for shared learning for staff across members including through CEO forums, communities of practice and one-off and periodic events.

  • Establish a workforce development program for members and community partners including continuous learning and skills development that enhances knowledge, practice and impact.

  • Include within the workforce development program learning for new community workers on foundational knowledge in viral hepatitis.
Better evidence and research
  • Co-create with researchers, members and people with lived experience of hepatitis B and hepatitis C an agenda for strategic and investigator-driven research.

  • Position Hepatitis Australia as the go-to partner for research that drives innovation and identify new ways to translate research to community and health settings.

  • Work with researchers to establish a clearer profile of hepatitis B and hepatitis C within Australia’s culturally and linguistically diverse communities and guide members on what this means for programming.

  • Advocate for improved completeness of Aboriginal and Torres Strait Islander identifiers in notification data for viral hepatitis.

  • Advocate for the mandatory recording of hepatitis B birth dose administration in the Australian Immunisation Register (AIR).

  • Work with researchers to promote data linkage that addresses research and surveillance gaps.
Innovation
  • Monitor the global evidence base and promote innovation that places Australia at the cutting edge of policy and practice.

  • Explore opportunities and manage the risks of artificial intelligence and new technologies for members and communities.

  • Document and share successful models of peer-led practice by people with lived experience of hepatitis B and hepatitis C in community hepatitis organisations